Acute necrotizing gastritis by Escherichia coli in a severely neutropenic patient.
Martínez-Chamorro
Carmen
C
Hematology Department, Clinica Ruber, C/Juan Bravo, 49 28006-Madrid, Spain. m-chamorro@navegalia.com
Martínez
Elena
E
Gil-Fernández
Juan José
JJ
Escudero
Antonio
A
Acevedo
Agustín
A
Fernández-Rañada
José Ma
JM
D000208:Acute Disease; D000583:Amikacin / Q000627:therapeutic use; D000741:Anemia, Aplastic / Q000150:complications* / Q000188:drug therapy; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000209:etiology*; D005753:Gastric Mucosa / Q000473:pathology*; D005756:Gastritis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000628:therapy; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D000077731:Meropenem; D008775:Methylprednisolone / Q000009:adverse effects / Q000627:therapeutic use; D009336:Necrosis; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications*; D009853:Omeprazole / Q000627:therapeutic use; D010289:Parenteral Nutrition, Total; D013601:T-Lymphocytes; D013845:Thienamycins / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D013845:Thienamycins; D016179:Granulocyte Colony-Stimulating Factor; D016572:Cyclosporine; D000583:Amikacin; D000077731:Meropenem; D009853:Omeprazole; D008775:Methylprednisolone